IT Matters: The Erectile Restoration Registry
Launched by BOSTON SCIENTIFIC CORPORATION · Dec 13, 2019
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
IT MATTERS is a prospective, multicenter, observational registry that is part of planned, active post market clinical follow-up (PMCF) activity associated with each device.
The study will include adult males who undergo penile prothesis implantation with a market approved BSC device to treat erectile dysfunction.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • 1. ≥ 18 years of age.
- • 2. Males who are determined to be suitable candidates and scheduled to undergo surgical implantation of a market approved BSC penile prothesis by their physician.
- • 3. Willing and able to complete the informed consent process.
- • 4. Willing and able to comply with the follow-up requirements.
- Exclusion Criteria:
- • 1. Males who are deemed by their physician as not suitable candidates for a penile prosthesis.
- • 2. In the opinion of the investigator, it is not in best interest of the patient or the study for the patient to participate.
About Boston Scientific Corporation
Boston Scientific Corporation is a global leader in medical device innovation, dedicated to providing solutions that enhance patient care and improve clinical outcomes. With a strong focus on advancing the treatment of various medical conditions, Boston Scientific develops and manufactures a diverse range of products across multiple specialties, including cardiology, urology, and endoscopy. The company is committed to rigorous clinical research and development, ensuring that its devices meet the highest standards of safety and efficacy. Through collaboration with healthcare professionals and ongoing investment in technology and education, Boston Scientific strives to deliver breakthrough therapies that address unmet medical needs and empower patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Milwaukee, Wisconsin, United States
Chicago, Illinois, United States
Winston Salem, North Carolina, United States
Springfield, Illinois, United States
Philadelphia, Pennsylvania, United States
Houston, Texas, United States
Salt Lake City, Utah, United States
Cleveland, Ohio, United States
Seattle, Washington, United States
Indianapolis, Indiana, United States
Saint Louis, Missouri, United States
St. Louis, Missouri, United States
Los Angeles, California, United States
Los Angeles, California, United States
Beijing, , China
Raleigh, North Carolina, United States
Miami, Florida, United States
Tampa, Florida, United States
Salisbury, North Carolina, United States
Columbus, Ohio, United States
Bossier City, Louisiana, United States
Los Angeles, California, United States
Dhahran, , Saudi Arabia
Patients applied
Trial Officials
Mohit Khera, MD
Principal Investigator
Baylor College of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials